APL-9

APL-9 · Apellis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APL-9, covering 2022-03-23 to 2022-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 [Phase 1, Phase 2]